MesotheliomaPhase 1NCT06885697
TNhYP218 CAR T Cells
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC
What the film says
For lung cancer driven by an ALK gene fusion, targeted pills work well, sometimes for years. Then resistance arrives; it almost always does.
The idea: vaccinate while the drug is still working, so the immune system learns the tumor before it changes.
The ALK fusion protein exists only in cancer cells, which makes it a clean target. At Johns Hopkins, patients whose disease is stable on an ALK inhibitor receive a peptide vaccine, fragments of the ALK protein with an immune adjuvant, to raise T cells against any cell carrying it. So when drug-resistant cells emerge, the immune system is already watching.
ARCHER is a small early safety study; the drug continues throughout. Vincent Lam leads it. Public record; not medical advice.
Sources behind this film
ALK inhibitors effective; acquired resistance near-universal; Vaccinate during stable disease on crizotinib/ceritinib/alectinib/brigatinib/lorlatinib; Peptide vaccine + adjuvant; Vincent Lam; Johns Hopkins; enrollment 12
The drug
The study drug is a prophylactic cancer peptide vaccine for advanced ALK-positive non-small cell lung cancer.
The study
The purpose of this study is to evaluate the safety of a cancer peptide vaccine to prevent or delay acquired resistance in advanced ALK+ lung cancer patients currently on ALK targeted therapy.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.